Deep Biotech: Disruptive innovation for global sustainability

The BIA has coined the term ‘Deep Biotech’ to capture companies working in this biotech space. This report aims to shine a light on some of the innovative companies using engineering biology to positively disrupt the environmentally damaging industries that modern society relies on.

UK biotech financing 2023

Despite the global economic downturn, UK life sciences companies secured £1.25 billion in venture financing, constituting 11% of the total venture capital investment in UK companies this year.

BIA's submission to HMT's Spring Budget 2024

The BIA has submitted a representation to HM Treasury ahead of the Spring Budget scheduled for March.

Influencing and shaping our sector BIA update: October 2023 - January 2024

An overview of the BIA's influencing work on behalf of the innovative life science and biotech sector between October 2023 and January 2024.

BIA submission to DBT’s call for evidence on smarter regulation

The BIA has responded to the Department for Business and Trade’s call for evidence on smarter regulation and the regulatory landscape

BIA submission to FSA consultation on precision bred organisms for food and feed

BIA response to NICE TA-HST charging review

BIA Webinar Recording: Reskilling for future growth technologies

This webinar provides an overview of the current landscape, areas of growth and investment, where to find training opportunities and the types of careers available across a broad spectrum of technologies including complex therapies, advanced manufacturing, data driven drug discovery and more.

Genomics nation 2023: A genomics-powered UK life science ecosystem

BIA webinar recording: The Chancellor's Autumn Statement 2023